Fig. 1 · Structure
Documents & Downloads
Urinary Incontinence-Targeting Compound 1
Drug Derivative
Urinary Incontinence-Targeting Compound 1 is a sulfonanilide derivative designed to interact with pathways involved in urinary incontinence. This compound exhibits key biological activity by modulating neurotransmitter signaling, which may influence bladder activity and control. It serves as a valuable tool in research focused on the mechanisms underlying urinary incontinence and the development of novel therapeutic strategies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 137315-05-0 |
| Applications | Drug Derivative |
| Formula | C9H13FN2O3S |
| Molecular Weight | 248.27 |
| SMILES | CS(=O)(NC1=CC=C(F)C(C(O)CN)=C1)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.